Neurotrophic cross-talk between the nervous and immune systems: Implications for neurological diseases

被引:215
作者
Kerschensteiner, M
Stadelmann, C
Dechant, G
Wekerle, H
Hohlfeld, R
机构
[1] Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland
[2] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland
[3] Univ Goeltingen, Inst Neuropathol, Gottingen, Germany
[4] Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Austria
[5] Max Planck Inst Neurobiol, Dept Neuroimmunol, Martinsried, Germany
[6] Univ Munich, Klinikum Grosshadern, Inst Clin Neuroimmunol, Munich, Germany
关键词
D O I
10.1002/ana.10446
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Inflammatory reactions in the central nervous system usually are considered detrimental, but recent evidence suggests that they also can be beneficial and even have neuroprotective effects. Intriguingly, immune cells can produce various neurotrophic factors of various molecular families. The concept of "neuroprotective immunity" will have profound consequences for the pathogenesis and treatment of neuroinflammatory diseases such as multiple sclerosis. It also will prove important for neurodegenerative disorders, in which inflammatory reactions often occur. This review focuses on recent findings that immune cells produce brain-derived neurotrophic factor in multiple sclerosis lesions, whereas neurons and astrocytes express the appropriate tyrosine kinase receptor TrkB. Together with functional evidence for the neuroprotective effects of immune cells, these observations support the concept of "neuroprotective immunity." We next examine current and future therapeutic strategies for multiple sclerosis and experimental autoimmune encephalomyelitis in light of neuroprotective immunity and finally address the broader implications of this new concept for other neuroinflammatory and neurodegenerative diseases.
引用
收藏
页码:292 / 304
页数:13
相关论文
共 161 条
[1]   Is the therapeutic application of neurotrophic factors dead? [J].
Apfel, SC .
ANNALS OF NEUROLOGY, 2002, 51 (01) :8-11
[2]  
Arredondo LR, 2001, EUR J IMMUNOL, V31, P625
[3]   The GDNF family ligands and receptors - implications for neural development [J].
Baloh, RH ;
Enomoto, H ;
Johnson, EM ;
Milbrandt, J .
CURRENT OPINION IN NEUROBIOLOGY, 2000, 10 (01) :103-110
[4]   Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease [J].
Bard, F ;
Cannon, C ;
Barbour, R ;
Burke, RL ;
Games, D ;
Grajeda, H ;
Guido, T ;
Hu, K ;
Huang, JP ;
Johnson-Wood, K ;
Khan, K ;
Kholodenko, D ;
Lee, M ;
Lieberburg, I ;
Motter, R ;
Nguyen, M ;
Soriano, F ;
Vasquez, N ;
Weiss, K ;
Welch, B ;
Seubert, P ;
Schenk, D ;
Yednock, T .
NATURE MEDICINE, 2000, 6 (08) :916-919
[5]   NEW NEUROTROPHIC FACTORS [J].
BARDE, YA ;
EDGAR, D ;
THOENEN, H .
ANNUAL REVIEW OF PHYSIOLOGY, 1983, 45 :601-612
[6]   Beneficial effects of lysine acetylsalicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis [J].
Barnéoud, P ;
Curet, O .
EXPERIMENTAL NEUROLOGY, 1999, 155 (02) :243-251
[7]   Differential regulation of neurotrophin expression by mitogens and neurotransmitters in mouse lymphocytes [J].
Barouch, R ;
Appel, E ;
Kazimirsky, G ;
Braun, A ;
Renz, H ;
Brodie, C .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 103 (02) :112-121
[8]   Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: Implications for protective autoimmunity [J].
Barouch, R ;
Schwartz, M .
FASEB JOURNAL, 2002, 16 (08) :1304-+
[9]   Macrophages express neurotrophins and neurotrophin receptors - Regulation of nitric oxide production by NT-3 [J].
Barouch, R ;
Appel, E ;
Kazimirsky, G ;
Brodie, C .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 112 (1-2) :72-77
[10]   A CRUCIAL ROLE FOR NEUROTROPHIN-3 IN OLIGODENDROCYTE DEVELOPMENT [J].
BARRES, BA ;
RAFF, MC ;
GAESE, F ;
BARTKE, I ;
DECHANT, G ;
BARDE, YA .
NATURE, 1994, 367 (6461) :371-375